Utility of Cardiovascular Imaging to Refine Cardiovascular Disease (CVD) Risk Assessment

被引:0
|
作者
Marcio Sommer Bittencourt
Edward A. Hulten
Khurram Nasir
Ron Blankstein
机构
[1] Brigham and Women’s Hospital and Harvard Medical School,Non
[2] Brigham and Women’s Hospital and Harvard Medical School,Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division)
[3] University Hospital,Non
[4] University of Sao Paulo,Invasive Cardiovascular Imaging Program, Department of Radiology
[5] Cardiology Service,undefined
[6] Walter Reed National Military Medical Center,undefined
[7] Center for Wellness and Prevention Research,undefined
[8] Baptist Health South Florida,undefined
关键词
Prevention; Cardiovascular disease; Coronary artery disease; Coronary artery calcium score; Cardiovascular imaging;
D O I
10.1007/s12170-014-0378-5
中图分类号
学科分类号
摘要
Various approaches exist for stratifying cardiovascular risk and predicting future cardiovascular events. While traditional approaches rely on risk scores, which are based on the presence or absence of various risk factors, noninvasive cardiovascular imaging allows for actual identification of coronary artery disease—whether by direct visualization of plaque or imaging—the physiologic manifestations of flow-limiting disease. The presence of such disease is associated with a significant increase in risk of future cardiovascular events and thus, should prompt intensification of preventive therapies. This review will highlight the role of cardiovascular imaging for evaluating disease in individuals without known prior coronary artery disease. The principal findings of each imaging technique will be reviewed and data regarding the risk associated with such findings will be discussed.
引用
收藏
相关论文
共 50 条
  • [31] Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease
    Sinh, Preetika
    Cross, Raymond
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (07) : 1107 - 1115
  • [32] Metabolic syndrome and goals of therapy for cardiovascular disease (CVD) risk
    Bardini, G.
    Pala, L.
    Cresci, B.
    Monami, M.
    Targioni, I.
    Sposato, I.
    Mannucci, E.
    Rotella, C. M.
    [J]. DIABETOLOGIA, 2007, 50 : S498 - S499
  • [33] Imaging Assessment of Cardiovascular Risk in Asymptomatic Adults
    Lin, Eugene
    Hwang, Wayne
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (06) : W1046 - W1051
  • [34] Risk assessment for CVD death: A device for rapid estimation of cardiovascular disease over 20 years
    Grimm, Richard, Jr.
    Svendson, Ken
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : 304 - 304
  • [35] TRANSFORMING CARDIOVASCULAR DISEASE RISK TO CARDIOVASCULAR HEALTH: OPPORTUNITIES TO EDUCATE YOUNG WOMEN ABOUT CVD
    Liu, Jingyi
    Goel, Shivani
    Brown, Courtney A.
    DeFerranti, Sarah
    Stamoulis, Caterina
    Gooding, Holly
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2020, 66 (02) : S70 - S70
  • [36] Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis
    Ormseth, Michelle J.
    Solus, Joseph F.
    Vickers, Kasey C.
    Oeser, Annette M.
    Raggi, Paolo
    Stein, C. Michael
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (10) : 1746 - 1751
  • [37] Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
    Mc Namara, Kevin P.
    George, Johnson
    O'Reilly, Sharleen L.
    Jackson, Shane L.
    Peterson, Gregory M.
    Howarth, Helen
    Bailey, Michael J.
    Duncan, Gregory
    Trinder, Peta
    Morabito, Elizabeth
    Finch, Jill
    Bunker, Stephen
    Janus, Edward
    Emery, Jon
    Dunbar, James A.
    [J]. BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [38] Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD
    Ebesunun, M. O.
    Agbedana, E. O.
    Taylor, G. O. L.
    Oladapo, O. O.
    [J]. APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2008, 33 (02) : 282 - 289
  • [39] Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
    Kevin P Mc Namara
    Johnson George
    Sharleen L O'Reilly
    Shane L Jackson
    Gregory M Peterson
    Helen Howarth
    Michael J Bailey
    Gregory Duncan
    Peta Trinder
    Elizabeth Morabito
    Jill Finch
    Stephen Bunker
    Edward Janus
    Jon Emery
    James A Dunbar
    [J]. BMC Health Services Research, 10
  • [40] Cardiovascular Risk Assessment Campaigns in Community Pharmacies: contributing to CVD prevention
    Paulino, Ema
    Paulino, Ines
    Guerreiro, Marilia
    Fortunato, Ana Leonor
    Remedios, Ana Filipa
    Rosa, Mariana
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 613 - 613